Welcome : Guest

Cymabay Therapeutics, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Cymabay Therapeutics, Inc., which is principally involved in Developing Therapies to treat Metabolic Diseases. Illustrated with 25 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-64169
Price: $1250
Company Type: Public
Pages: 26
Date: September 2016
Market Data Tables: 25

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Cardiovascular......2
Table 1: Cardiovascular Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, Anti-Arrhythmics, Anti-Thrombotics, Beta Blockers, Calcium Channel Blockers, Cholesterol, GP IIb/IIIa Inhibitors, Vasodilators, and Others......2
Diabetes......3
Table 2: Diabetes Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Delivery Devices, Glucose Monitoring, Insulin, and Oral Medication......3
Table 3: Diabetes Market by Region Worldwide (2015) - Percentage Share Breakdown for Africa, Europe, Middle East & North Africa, North America & Caribbean, Southeast Asia, and Western Pacific......4
Table 4: Diabetes Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Insulin Type-1 Diabetes, Insulin Type-2 Diabetes, Dipeptidyl Peptidase 4, (DPP4), Glucagon-like Peptide-1 (GLP-1), Dipeptidyl Peptidase 4, (DPP4) + Biguanide, and Others* (includes Sodium-Glucose Co-Transporter-2 (SGLT2), Biguanide, Sulfonylurea, Alpha-Glucosidase Inhibitors, Peroxisome Proliferator-Activated Receptor (PPAR)......5
Table 5: Type II Diabetes Market by Insulin Treatment Worldwide (2015) - Percentage Share Breakdown by Value for Diet and Exercise Only, Insulin and Orals and Insulin Only......6
Table 6: Type-II Diabetes Treatments Market Worldwide (2015-2020) in US$ Million......7
Table 7: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown for Insulin Pumps, and Multiple Daily Injections......8
Table 8: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown by Value for Type 1, and Type 2......9
Table 9: No. of Diabetes Patients by Medication in the US (2015) - Percentage Share Breakdown for Insulin and Oral Medication, Insulin Only, No Medication, and Oral Medication Only......10
Table 10: Type 1 Diabetes Market by Medical Device in the US (2015) - Percentage Share Breakdown by Value for Insulin Pumps and Multiple Daily Injections......11
Table 11: Type 1 Diabetes Market by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Continuous Glucose Monitoring Users, and Non-Continuous Glucose Monitoring Users......12
Diabetes Drugs......13
Table 12: Diabetes Drug Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-4 Inhibitor, GK Activator, GLP-1 Agonist, GPCR Agonist, IL- Receptor Antagonist, Insulin Analogue, PPAR Agonist, SGLT-2 Inhibitor, and Others......13
Table 13: Diabetes/Metabolic Drugs Market by Category Worldwide (2015) - Percentage Breakdown by Value Sales for DPP-IV Inhibitors, Glitazones, GLP-1 Analogs, Insulins, Sulfonylureas, and Others......14
Table 14: Diabetes Drugs Market by Product Category in China (2015) - Percentage Share Breakdown by Value for Acarbose, Insulin, Melbine, and Other Diabetes Drugs......15
Table 15: Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glinide, Insulin, Sulfonylureas, α-glucosidase Inhibitor, and Others......16
Table 16: Diabetic Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value for DPP-IV & SGLT-2, GLP-1, Insulins, and Others......17
Table 17: Diabetic Drugs Market by Non-Insulin Therapy in the US (2015) - Percentage Share Breakdown by Volume for Biguanides, DPP-4 Inhibitor, Human GLP-1 Analogs, SGLT-2 Inhibitor, Sulfonylureas, and Others......18
Diabetic Macular Edema (DME)......19
Table 18: Diabetic Macular Edema (DME) Market by Drug Treatment Worldwide (2015) - Percentage Share Breakdown by Volume for Avastin, Laser Photocoagulation, Lucentis 0.3 mg, Steroids and Others......19
Gastrointestinal Drugs......20
Table 19: Gastrointestinal Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for H2 Blockers, Proton Pump Inhibitors, and Others......20
Table 20: Gastroesophageal Reflux Disease (GERD) Drugs Market by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Aciphex, Dexiant, Lansporazole, Nexium, Omeprazole, and Others......21
Orphan Drugs......22
Table 21: Specialty Pharma & Orphan Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, US and Rest of the World......22
Cardio-Cerebral Vascular (CCV) Drugs......23
Table 22: Market Shares of Leading Cardio-Cerebral Vascular (CCV) Drugs Manufacturers in China (2015) - Percentage Share Breakdown by Value for Sihuan Pharmaceutical Holdings Group Ltd., Sanofi S.A., Qilu pharmaceutical Co., Ltd. and Others......23
Cardiology Therapeutics......24
Table 23: Market Shares of Leading Cardiology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......24
Diabetes/Metabolic Therapeutics......25
Table 24: Market Shares of Leading Diabetes Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......25
Orphan Disease Therapeutics......26
Table 25: Market Shares of Leading Orphan Disease Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Pfizer, Inc., Sanofi S.A., and Others......26